Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1676 to 1700 of 2428

TitleReference numberPublishedLast updated
Coronary revascularisation: CangrelorESNM63
Tolvaptan for treating autosomal dominant polycystic kidney diseaseTA358
Idelalisib for treating chronic lymphocytic leukaemiaTA359
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)TA362
Implanting a baroreceptor stimulation device for resistant hypertensionIPG533
Developing and updating local formulariesMPG1
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onsetNG16
Bipolar disorder, psychosis and schizophrenia in children and young peopleQS102
PROPATEN heparin-bonded vascular graft for peripheral arterial diseaseMIB42
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay)DG18
Orthostatic hypotension due to autonomic dysfunction: midodrineESNM61
ERBE flexible cryoprobes for bronchoscopic diagnosis and treatmentMIB39
Active B12 assay for diagnosing vitamin B12 deficiencyMIB40
Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancerIPG532
Home care: delivering personal care and practical support to older people living in their own homesNG21
Thermogard XP for therapeutic hypothermia after cardiac arrestMIB37
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency departmentMIB38
Secondary prevention after a myocardial infarctionQS99
Coeliac disease: recognition, assessment and managementNG20
Hypertension in adultsQS28
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)TA353
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolismTA354
Preoperative high dose rate brachytherapy for rectal cancerIPG531
Transcranial direct current stimulation (tDCS) for depressionIPG530

Results per page

  1. 10
  2. 25
  3. 50
  4. All